Harnessing the link between the human gut microbiome and the central nervous system to develop a new class of therapeutics to improve the quality of life for people with CNS diseases and disorders.

Dr. Westphal, Dr. Donabedian, and Mr. Aldrich founded Axial Biotherapeutics with Dr. Sarkis Mazmanian, of California Institute of Technology, a recipient of the MacArthur Foundation “Genius” award. Dr. Donabedian serves as CEO and Mr. Aldrich serves as a director. Axial harnesses the link between the human gut microbiome and the Central Nervous System to develop a new class of therapeutics to improve the quality of life for people with CNS diseases including Parkinson’s Disease and Autism Spectrum Disorder.

Visit Site

Related Press